B Capital SEA

B Capital is a global multi-stage technology investor co-founded with Eduardo Saverin, with a deep bench in Singapore that explicitly targets transformational healthcare technology in Southeast Asia. Within the firm’s franchise, the SEA team operates at the intersection of US-style growth-stage rigour and a regional network that includes BCG as a strategic partner, which gives portfolio companies measurable enterprise distribution leverage. The fund writes Series B through growth cheques in the $10M-$25M+ band and concentrates on Health IT, AI/ML applied to clinical workflow, and digital health platforms with provable enterprise adoption. The right founder profile is a Series B-ready company with multi-country traction across Singapore, Indonesia, Vietnam, or the Philippines, audited revenue in the high single-digit to low-double-digit millions, and a defensible AI or data moat. Pre-Series B founders, single-country plays, and pure consumer wellness brands should not approach. The cleanest intro path is a B Capital portfolio CEO, a BCG senior partner with healthcare practice exposure, or a US-based growth fund that already syndicates with B Capital. In the pitch, lead with enterprise contract economics, hospital or payer logos, gross margin profile, and a clear thesis on regional expansion; their global team will benchmark you against US comparables, so be prepared to defend valuation against multiples in mature markets. Caveats: B Capital’s process is institutional, with multiple committees and cross-office reference checks, so plan for a multi-month cycle. The SEA team is also disciplined about avoiding overpaying in down markets, so be ready for a structured term sheet with strong governance terms rather than founder-friendly froth. Founders should also clarify reserves and follow-on commitments early, given the firm’s preference for concentrated positions across the lifecycle.